3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other
1
Genitourinary
1
Conditions
Prostatic Neoplasms
45
Breast Neoplasms
15
Leiomyoma
3
Cardiovascular Diseases
3
Polycystic Ovary Syndrome
2
Neoplasms
2
Endometrial Neoplasms
2
Advanced Breast Cancer
2
Stage II Prostate Adenocarcinoma
1
Sexual Dysfunctions, Psychological
1
Sarcopenia
1
Salivary Gland Adenoma, Pleomorphic
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatectomy
1
Prostate Cancer With ≤10 Bone Metastases
1
Prostate Cancer Metastatic Disease
1
Prostate Cancer Metastatic
1
Pelvic Pain
1
Oligometastatic Prostate Carcinoma
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplasm Metastasis
1
Metastatic Castration-resistant Prostate Cancer
1
Metabolic Syndrome
1
Metabolic Diseases
1
Kallmann Syndrome
1
Inflammatory Breast Neoplasms
1
Infertility
1
Hypogonadism
1
Hyperprolactinemia
1
Interventions
Metformin
7
Testosterone
2
Magnetic Resonance Spectroscopy
2
Inositol
2
Exercise
2
Ethinyl Estradiol
2
Blood Pressure
2
semaglutide
1
maltodextrin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Walking
1
Vascular Stiffness
1
Ultrasonography
1
Triptorelin Pamoate
1
Topiramate
1
Tirzepatide
1
Sugars
1
Spironolactone
1
Qsymia
1
Pyruvic Acid
1
Pulse Wave Analysis
1
Preoperative Exercise
1
Pioglitazone
1
Phlebotomy
1
Phentermine
1
Pancreaticoduodenectomy
1
Orchiectomy
1
Naltrexone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Metabolic Syndrome
×
Gonadotropin-Releasing Hormone
×
Clear all
NCT05773183
2023-03-17
MMetdMH
Royal College of Surgeons, Ireland
Unknown
60 enrolled